M. Viswanathan et al., [I-125] CGP-42112 REVEALS A NON-ANGIOTENSIN II BINDING-SITE IN 1-METHYL-4-PHENYLPYRIDINE (MPP(-INDUCED BRAIN INJURY())), Cellular and molecular neurobiology, 14(1), 1994, pp. 99-104
1. Intracerebral injection of the oxidative metabolite of 1-methyl-4-p
henyl-1,2,3,6-tetrahydropyridine (MPTP), 1-methyl-4-phenylpyridine (MP
P(+)), into the substantia nigra of adult rats resulted in a lesion at
the injection site. 2. Using autoradiography, we localized specific [
I-125]CGP 42112 binding that was not recognized by angiostensin II or
angiotensin II AT(1) or AT(2) receptor-selective ligands. 3. Our resul
ts suggest that [I-125]CGP 42112 may be binding to activated microglia
that appear at the lesion site.